Tuesday
SESSION 5: NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
SESSION 5 SCHEDULE
1:00 PM - 1:05 PM Update On The ACT I Trial Comparing CAS And CEA In Patients With High-Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):Jon S. Matsumura, MD  
1:06 PM - 1:11 PM CAS Is Equivalent To CEA In Many Circumstances
  Presenter(s):William A. Gray, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM DEBATE: Not So: Lessons Learned From US Datasets On Outcomes After CEA And CAS Show CAS Results Are Substantially Worse Than In CREST: The Brighter The Light The Darker The Shadow
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
TWO-WAY DEBATE
1:18 PM - 1:23 PM DEBATE: Late Results Of ICSS Trial Show CAS And CEA To Be Equivalent In Patients With Symptomatic Carotid Stenosis
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM DEBATE: Late Results Of ICSS Do Not Show Equivalence Of CAS And CEA: CEA Still Wins For Symptomatic Carotid Stenosis
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
1:30 PM - 1:35 PM Stroke And Death Rates (Early And Late) After CAS Are Higher Than The Randomized Controlled Trials (RCTs) Would Indicate: Therefore, We Should Be Less Aggressive With Our Use Of CAS Especially In The Elderly And Asymptomatic Patients
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Asymptomatic Carotid Stenosis (ACS) Up To 80% Is Benign: What About Those Stenoses Over 85% - Especially When Associated With A Contralateral Occlusion: Which ACS Patients Should Be Treated Invasively And How
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
1:42 PM - 1:47 PM Long-Term Results Of The SAMMPRIS (Intracranial Stenting) Trial In Patients With Intracranial Stenoses: What Does It Tell Us About Best Medical Treatment (BMRx); Compliance And Long-Term Benefits: The Recent VISSIT Trial Confirms The Negative Effects Of Intracranial Stenting
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
Moderator(s): Wesley S. Moore, MD / Thomas S. Riles, MD  
1:55 PM - 2:00 PM Why Transcranial Doppler (TCD) Is Essential Before, During And After CAS, CEA And TAVI
  Presenter(s):Zsolt Garami, MD  
2:01 PM - 2:06 PM Status Of Endovascular Treatment Of Total Carotid Occlusions: Advantages, Technique, Complications And How To Avoid Them
  Presenter(s):Paul H.L. Kao, MD  
  View Slides in PDF      
2:07 PM - 2:12 PM Diaphragm Of The Internal Carotid Artery: An Underdiagnosed Cause Of Stroke
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
2:13 PM - 2:18 PM DEBATE: Carotid Plaque Morphology Is Only Important In Symptomatic Patients
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Slides in PDF      
2:19 PM - 2:24 PM DEBATE: Not So: Carotid Plaque Morphology Is Helpful (With Other Criteria) In Predicting Stroke Risk In ACS Patients: What Percent Of ACS Patients Are High Risk And Justifiably Need CEA Or CAS
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Slides in PDF      
2:25 PM - 2:30 PM Risk Stratification Of Patients With Carotid Stenosis: How To Quantify: An Aging Brain Is More Important Than Plaque Characteristics And Even Symptom Status
  Presenter(s):Thomas G. Brott, MD  
  View Slides in PDF      
2:31 PM - 2:36 PM Importance Of Preoperative And Perioperative Statin Dosage In Patients With Carotid Stenosis: Can They Change And Shrink Plaque: How Often
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Slides in PDF      
2:37 PM - 2:42 PM What Is New In The Effects Of Carotid Disease And Carotid Treatments (CEA And CAS) On Cognitive Function: Are There Differences Between CEA And CAS
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
2:43 PM - 2:48 PM Tips And Tricks For Obtaining Distal Exposure Of The Internal Carotid Artery To The Skull Base: Your ENT Surgeon Colleagues Can Help
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
2:49 PM - 2:55 PM Panel Discussion
2:55 PM - 3:05 PM Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
previous next